v3.0.7
Please consider this website is continuously evolving and still under development
to harmonize automatic data extraction and integrate manual data annotation.
Column | Value |
---|---|
Trial registration number | IRCT20200818048444N1 |
Full text link
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
First author
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
Contact
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Samiei.moh@gmail.com |
Registration date
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2020-09-15 |
Recruitment status
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Completed |
Study design
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
RCT |
Allocation
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Randomized |
Design
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Parallel |
Masking
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Blind label |
Center
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
single-center |
Study aim
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Treatment |
Inclusion criteria
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
18 years and older, both sexes Having home contact, unmasked contact with a patient with Covid-19 confirmed by RT-PCR or clinical evidence or radiography of pneumonia and acute respiratory distress syndrome (ARDS); No clinical signs of Covid-19 (fever, cough, dyspnea, shortness of breath, sore throat, extreme tiredness, digestive problems); No chronic respiratory problems or other illnesses that are mistaken for symptoms of COVID-19 |
Exclusion criteria
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Involvement with any other ongoing studies. Pregnant or breast feeding woman or with positive pregnancy test result for fetal safety Severe liver disease as a strong confounding factor Severe renal failure as a strong confounding factor Refusal by attending physician for no clinical equipoise Advanced active malignancy as a strong confounding factor Patient in other clinical trials for COVID-19 within 30 days before/after ICF as a confounding factor/s Other patient characteristics (not thought to be related to underlying COVID-19) that portend a very poor prognosis (e.g, severe liver failure, severe renal failure, and etc. May impact primary and other clinical endpoints- Known allergy to study drug or its ingredients related to renin-angiotensin system (RAS), or frequent and/or severe allergic reactions with multiple medications for patient protection purposes Other uncontrolled disease, as judged by investigators that may influence study endpoint and other clinical outcome |
Number of arms
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2 |
Funding
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Tabriz University of Medical Sciences |
Inclusion age min
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
18 |
Inclusion age max
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
100 |
Countries
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Iran |
Type of patients
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Mild/moderate disease at enrollment |
Severity scale
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
2: Mild/moderate disease at enrollment |
Total sample size
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
1300 |
primary outcome
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Test for the presence or absence of nucleic acid in the corona virus Serum IgM and IgG levels |
Notes
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
|
Phase
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
Phase 3 |
Arms
Last imported at : Oct. 26, 2020, 8:37 a.m. Source : Iranian Registry of Clinical Trials (IRCT) |
[{"arm_notes": "", "treatment_id": 240, "treatment_name": "Bromhexine hydrochloride", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}] |